BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30037791)

  • 1. Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.
    Shukla S; Richardson ET; Drage MG; Boom WH; Harding CV
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037791
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2.
    Drage MG; Tsai HC; Pecora ND; Cheng TY; Arida AR; Shukla S; Rojas RE; Seshadri C; Moody DB; Boom WH; Sacchettini JC; Harding CV
    Nat Struct Mol Biol; 2010 Sep; 17(9):1088-95. PubMed ID: 20694006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Lipoprotein Rv1016c Derived from
    Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
    Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.
    Lancioni CL; Li Q; Thomas JJ; Ding X; Thiel B; Drage MG; Pecora ND; Ziady AG; Shank S; Harding CV; Boom WH; Rojas RE
    Infect Immun; 2011 Feb; 79(2):663-73. PubMed ID: 21078852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
    Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
    J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion.
    Shukla S; Richardson ET; Athman JJ; Shi L; Wearsch PA; McDonald D; Banaei N; Boom WH; Jackson M; Harding CV
    PLoS Pathog; 2014 Oct; 10(10):e1004471. PubMed ID: 25356793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis 19-kDa lipoprotein induces Toll-like receptor 2-dependent peroxisome proliferator-activated receptor γ expression and promotes inflammatory responses in human macrophages.
    Liu L; Liu J; Niu G; Xu Q; Chen Q
    Mol Med Rep; 2015 Apr; 11(4):2921-6. PubMed ID: 25504154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LprG-mediated surface expression of lipoarabinomannan is essential for virulence of Mycobacterium tuberculosis.
    Gaur RL; Ren K; Blumenthal A; Bhamidi S; González-Nilo FD; Jackson M; Zare RN; Ehrt S; Ernst JD; Banaei N
    PLoS Pathog; 2014 Sep; 10(9):e1004376. PubMed ID: 25232742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.
    Drage MG; Pecora ND; Hise AG; Febbraio M; Silverstein RL; Golenbock DT; Boom WH; Harding CV
    Cell Immunol; 2009; 258(1):29-37. PubMed ID: 19362712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein O-mannosylation deficiency increases LprG-associated lipoarabinomannan release by Mycobacterium tuberculosis and enhances the TLR2-associated inflammatory response.
    Alonso H; Parra J; Malaga W; Payros D; Liu CF; Berrone C; Robert C; Meunier E; Burlet-Schiltz O; Rivière M; Guilhot C
    Sci Rep; 2017 Aug; 7(1):7913. PubMed ID: 28801649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.
    Ranoa DRE; Kelley SL; Tapping RI
    J Biol Chem; 2013 Apr; 288(14):9729-9741. PubMed ID: 23430250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.
    Schlesinger LS; Hull SR; Kaufman TM
    J Immunol; 1994 Apr; 152(8):4070-9. PubMed ID: 8144972
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Hook JS; Cao M; Weng K; Kinnare N; Moreland JG
    J Immunol; 2020 Feb; 204(3):671-681. PubMed ID: 31871022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
    Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
    Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.
    Takeuchi O; Sato S; Horiuchi T; Hoshino K; Takeda K; Dong Z; Modlin RL; Akira S
    J Immunol; 2002 Jul; 169(1):10-4. PubMed ID: 12077222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling.
    Tapping RI; Tobias PS
    J Endotoxin Res; 2003; 9(4):264-8. PubMed ID: 12935358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rLrp of Mycobacterium tuberculosis inhibits proinflammatory cytokine production and downregulates APC function in mouse macrophages via a TLR2-mediated PI3K/Akt pathway activation-dependent mechanism.
    Liu Y; Li JY; Chen ST; Huang HR; Cai H
    Cell Mol Immunol; 2016 Nov; 13(6):729-746. PubMed ID: 26166760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.
    Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ
    J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannan chain length controls lipoglycans signaling via and binding to TLR2.
    Nigou J; Vasselon T; Ray A; Constant P; Gilleron M; Besra GS; Sutcliffe I; Tiraby G; Puzo G
    J Immunol; 2008 May; 180(10):6696-702. PubMed ID: 18453589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function.
    Pecora ND; Gehring AJ; Canaday DH; Boom WH; Harding CV
    J Immunol; 2006 Jul; 177(1):422-9. PubMed ID: 16785538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.